Cogent Biosciences Inc
Change company Symbol lookup
Select an option...
COGT Cogent Biosciences Inc
VONG Vanguard Russell 1000 Growth Index Fund ETF Shares
DPRO Draganfly Inc
BCIM abrdn Bloomberg Industrial Metals Strategy K-1 Free ETF
BCH Banco de Chile
BCEL Atreca Inc
BCDF Horizon Kinetics Blockchain Development ETF
BCDA BioCardia Inc
BCBP BCB Bancorp Inc
BCAT Black Rock Capital Allocation Trust

Health Care : Biotechnology | Small Cap Value
Company profile

Cogent Biosciences, Inc. is a biotechnology company that is focused on developing precision therapies for genetically defined diseases. The Company’s most advanced clinical program, bezuclastinib (CGT9486), is a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. KIT D816V is responsible for driving systemic mastocytosis, a serious disease caused by unchecked proliferation of mast cells. In addition to bezuclastinib, the Company is developing a portfolio of novel targeted therapies to help patients fighting serious, genetically driven diseases. The Company has initiated APEX, a Phase II clinical study of bezuclastinib in patients with AdvSM. APEX is an open-label, global, multicenter study evaluating the safety, efficacy, pharmacokinetic, and pharmacodynamic profiles of bezuclastinib. It also initiated Peak, a randomized, open-label, global Phase III clinical trial.

Closing Price
Day's Change
-0.45 (-3.08%)
B/A Size
Day's High
Day's Low

10-day average volume:

DZS Partners with EPS Global to Accelerate Next Generation Access Infrastructure Adoption in EMEA and Asia

2:00 am ET May 25, 2022 (Globe Newswire) Print

EQNX::TICKER_START (NASDAQ:DZSI), EQNX::TICKER_END DZS (Nasdaq: DZSI), a global leader in access networking infrastructure, service assurance and consumer experience software solutions, today announced a value-added distribution partnership with EPS Global, an award-winning leading distributor of specialized IT components. The agreement, which focuses on accelerating the adoption of next generation access infrastructure in Europe, the Middle East, Africa (EMEA) and Asia, brings together the leading-edge broadband access technology from DZS and matches it with the renowned local support, logistics management and technical expertise of EPS Global. Through this agreement, DZS will become one of EPS Global's key fiber broadband connectivity vendors enabling this innovative distributor to provide its customers with world-class DZS XCelerate solutions, including software-defined Passive Optical Networks (PON) infrastructure as well as powerful in-home WiFi solutions. DZS will be discussing this and all other company news, developments and solutions at the FTTH Conference 2022, the world's largest fiber summit taking place in Vienna on May 23-25, Halle B, at stand P01.

"Service Providers need to accelerate their networks fast to meet demands in connectivity, and we see DZS as a key partner to address this broadband access opportunity," said Colin Lynch, CEO and Co-Founder of EPS Global. "With their leading DZS Velocity Broadband Connectivity and DZS Helix Connected Home & Business solutions, our customers will be able to provide their own subscribers with the ultimate high-speed, immersive and virtual experiences, whether at work, home or at school. DZS solutions are especially suited for the significant broadband stimulus opportunities in Europe - including the £5.5 billion Project Gigabit in the United Kingdom, the EUR24 billion France Very High Speed Plan (PFTHD) and the EUR14 billion Federal Ministry for Digital and Transport (BMVI) in Germany - and to support service providers in Africa where we are seeing significant broadband buildout."

Through the partnership, EPS Global will offer its service provider customers access to the full lineup of DZS Broadband Connectivity infrastructure and Connected Home & Business solutions.

"EPS Global is a world-class distribution partner and we are thrilled to collaborate and support EPS Global as they deliver a differentiated sales experience to their customers, offering high-quality products that can transform their network performance and elevate their customer's in-home broadband experience," said Tim Mendoza, Vice President of Global Channel Sales at DZS. "We look forward to working with EPS Global to meet the evolving needs of national and regional service provider customers across EMEA and appreciate the synergies between our two companies in driving emerging broadband applications enabled by fiber."

EPS Global was founded in 1999 in Dublin, Ireland and currently has 430+ staff in 28 global locations in 16 countries across Europe, Asia and the Americas. With regional distribution hubs worldwide stocking products, lead and transit times are minimized for customers. EPS Global was awarded Top 20 SDN Solution Providers in North America and Top 50 Best Companies to Watch in 2018.

To learn more about DZS, visit

About DZS

DZS Inc. (NSDQ: DZSI) a global leader in access networking infrastructure, service assurance and consumer experience software solutions.

DZS, the DZS logo, and all DZS product names are trademarks of DZS Inc. Other brand and product names are trademarks of their respective holders. Specifications, products, and/or product names are all subject to change.

This press release contains forward-looking statements regarding future events and our future results that are subject to the safe harbors created under the Private Securities Litigation Reform Act of 1995. These statements reflect the beliefs and assumptions of the Company's management as of the date hereof. Words such as "anticipate," "believe," "continue," "could," "estimate," "expect," "forecast," "goal," "intend," "may," "plan," "project," "seek," "should," "target," "will," "would," variations of such words, and similar expressions are intended to identify forward-looking statements. Readers are cautioned that these forward-looking statements are only predictions and are subject to risks, uncertainties and assumptions that are difficult to predict. The Company's actual results could differ materially and adversely from those expressed in or contemplated by the forward-looking statements. Factors that could cause actual results to differ include, but are not limited to, those risk factors contained in the Company's SEC filings available at, including without limitation, the Company's annual report on Form 10-K, quarterly reports on Form 10-Q and subsequent filings. In addition, additional or unforeseen affects from the COVID-19 pandemic and the global economic climate may give rise to or amplify many of these risks. Readers are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date on which they are made. DZS undertakes no obligation to update or revise any forward-looking statements for any reason.

For further information see:

DZS on Twitter:

DZS on LinkedIn:

Press Inquiries:
McKenzie Hurst, Thatcher+Co.
Phone: +1 408.888.6787

Press Inquiries:
McKenzie Hurst, Thatcher+Co.
Phone: +1 408.888.6787

comtex tracking


Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.